Syndetics cover image
Image from Syndetics

Morgan Life Sciences / Ben Flaumenhaft & Constance E. Bagley.

By: Contributor(s): Material type: TextSeries: Publisher: [London] : SAGE, 2016Description: 1 online resource : illustrations (black and white, and colour)Content type:
  • text
  • still image
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781473973343 (ebook) :
Subject(s): DDC classification:
  • 658.406 23
Online resources: Morgan Life Sciences was a biotechnology firm headquartered in Waltham, Massachusetts. Initially, it focused on generic and over-the-counter medications, which it manufactured and distributed to drugstores and supermarket chains. Morgan completed a successful initial public offering in 1994, but by the late 1990s, the generics market had become increasingly competitive. Morgan steadily lost ground as its larger, low-cost competitors pushed prices relentlessly downward. This study explains how CEO Wendy Shaw set about transforming the fortunes of the company.
No physical items for this record

Originally Published in: Flaumenhaft, B., & Bagley, C. E. (2008). Morgan Life Sciences. 08-021. New Haven, CT: Yale School of Management, Yale University.

Morgan Life Sciences was a biotechnology firm headquartered in Waltham, Massachusetts. Initially, it focused on generic and over-the-counter medications, which it manufactured and distributed to drugstores and supermarket chains. Morgan completed a successful initial public offering in 1994, but by the late 1990s, the generics market had become increasingly competitive. Morgan steadily lost ground as its larger, low-cost competitors pushed prices relentlessly downward. This study explains how CEO Wendy Shaw set about transforming the fortunes of the company.

Description based on online resource; title from home page (viewed on May 3, 2016).

Licensed e-book